163 related articles for article (PubMed ID: 2955051)
1. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.
Nencioni L; Villa L; Tagliabue A; Antoni G; Presentini R; Perin F; Silvestri S; Boraschi D
J Immunol; 1987 Aug; 139(3):800-4. PubMed ID: 2955051
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes.
Nencioni L; Villa L; Tagliabue A; Boraschi D
Lymphokine Res; 1987; 6(4):335-9. PubMed ID: 3501509
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of in vivo immune response by tumor necrosis factor.
Ghiara P; Boraschi D; Nencioni L; Ghezzi P; Tagliabue A
J Immunol; 1987 Dec; 139(11):3676-9. PubMed ID: 3500228
[TBL] [Abstract][Full Text] [Related]
4. Functional maturation of thymocytes: recruitment of helper cells in the humoral immune response to SRBC in vitro by recombinant interleukin 1 (Il-1).
Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):331-8. PubMed ID: 2534786
[TBL] [Abstract][Full Text] [Related]
5. Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo.
Boraschi D; Villa L; Volpini G; Bossù P; Censini S; Ghiara P; Scapigliat G; Nencioni L; Bartalini M; Matteucci G
Eur J Immunol; 1990 Feb; 20(2):317-21. PubMed ID: 2311646
[TBL] [Abstract][Full Text] [Related]
6. In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice.
Frasca D; Boraschi D; Baschieri S; Bossu P; Tagliabue A; Adorini L; Doria G
J Immunol; 1988 Oct; 141(8):2651-5. PubMed ID: 2971727
[TBL] [Abstract][Full Text] [Related]
7. IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha.
Reed SG; Pihl DL; Conlon PJ; Grabstein KH
J Immunol; 1989 May; 142(9):3129-33. PubMed ID: 2523425
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo.
Takatsuki F; Okano A; Suzuki C; Chieda R; Takahara Y; Hirano T; Kishimoto T; Hamuro J; Akiyama Y
J Immunol; 1988 Nov; 141(9):3072-7. PubMed ID: 2459240
[TBL] [Abstract][Full Text] [Related]
9. Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production.
Reed SG; Pihl DL; Grabstein KH
J Immunol; 1989 Mar; 142(6):2067-71. PubMed ID: 2522132
[TBL] [Abstract][Full Text] [Related]
10. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
[TBL] [Abstract][Full Text] [Related]
11. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.
Koyama N; Harada N; Takahashi T; Mita S; Okamura H; Tominaga A; Takatsu K
Immunology; 1988 Feb; 63(2):277-83. PubMed ID: 3280472
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants.
Boraschi D; Tagliabue A
Methods; 1999 Sep; 19(1):108-13. PubMed ID: 10525446
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide.
Shao HJ; Chen L; Shen MS; Yu GF
Acta Virol; 2003; 47(4):217-21. PubMed ID: 15068376
[TBL] [Abstract][Full Text] [Related]
14. T helper cells required for the in vitro primary antibody response to SRBC are neither SRBC-specific nor MHC-restricted.
Feeney AJ; Corvalan JR; Matzinger P; Howard JC
J Mol Cell Immunol; 1984; 1(4):211-22. PubMed ID: 6242859
[TBL] [Abstract][Full Text] [Related]
15. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice.
Forni G; Musso T; Jemma C; Boraschi D; Tagliabue A; Giovarelli M
J Immunol; 1989 Jan; 142(2):712-8. PubMed ID: 2463312
[TBL] [Abstract][Full Text] [Related]
17. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
18. A role for T cell helper factors in antibody responses to "T-independent" antigens.
Endres RO; Kushnir E; Kappler JW; Marrack P; Kinsky SC
Lymphokine Res; 1982; 1(4):99-106. PubMed ID: 6240575
[TBL] [Abstract][Full Text] [Related]
19. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
20. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
Peterson LB; Wilner GD; Thomas DW
J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
